210 related articles for article (PubMed ID: 31015293)
1. Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease.
Ferrari Bardile C; Garcia-Miralles M; Caron NS; Rayan NA; Langley SR; Harmston N; Rondelli AM; Teo RTY; Waltl S; Anderson LM; Bae HG; Jung S; Williams A; Prabhakar S; Petretto E; Hayden MR; Pouladi MA
Proc Natl Acad Sci U S A; 2019 May; 116(19):9622-9627. PubMed ID: 31015293
[TBL] [Abstract][Full Text] [Related]
2. Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.
Jin J; Peng Q; Hou Z; Jiang M; Wang X; Langseth AJ; Tao M; Barker PB; Mori S; Bergles DE; Ross CA; Detloff PJ; Zhang J; Duan W
Hum Mol Genet; 2015 May; 24(9):2508-27. PubMed ID: 25609071
[TBL] [Abstract][Full Text] [Related]
3. Abnormal Spinal Cord Myelination due to Oligodendrocyte Dysfunction in a Model of Huntington's Disease.
Ferrari Bardile C; Sidik H; Quek R; Yusof NABM; Garcia-Miralles M; Pouladi MA
J Huntingtons Dis; 2021; 10(3):377-384. PubMed ID: 34366364
[TBL] [Abstract][Full Text] [Related]
4. Human ESC-Derived Chimeric Mouse Models of Huntington's Disease Reveal Cell-Intrinsic Defects in Glial Progenitor Cell Differentiation.
Osipovitch M; Asenjo Martinez A; Mariani JN; Cornwell A; Dhaliwal S; Zou L; Chandler-Militello D; Wang S; Li X; Benraiss SJ; Agate R; Lampp A; Benraiss A; Windrem MS; Goldman SA
Cell Stem Cell; 2019 Jan; 24(1):107-122.e7. PubMed ID: 30554964
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome-proliferator-activated receptor gamma coactivator 1 α contributes to dysmyelination in experimental models of Huntington's disease.
Xiang Z; Valenza M; Cui L; Leoni V; Jeong HK; Brilli E; Zhang J; Peng Q; Duan W; Reeves SA; Cattaneo E; Krainc D
J Neurosci; 2011 Jun; 31(26):9544-53. PubMed ID: 21715619
[TBL] [Abstract][Full Text] [Related]
6. Laquinimod Treatment Improves Myelination Deficits at the Transcriptional and Ultrastructural Levels in the YAC128 Mouse Model of Huntington Disease.
Garcia-Miralles M; Yusof NABM; Tan JY; Radulescu CI; Sidik H; Tan LJ; Belinson H; Zach N; Hayden MR; Pouladi MA
Mol Neurobiol; 2019 Jun; 56(6):4464-4478. PubMed ID: 30334188
[TBL] [Abstract][Full Text] [Related]
7. Oligodendrocyte pathology in Huntington's disease: from mechanisms to therapeutics.
Ferrari Bardile C; Radulescu CI; Pouladi MA
Trends Mol Med; 2023 Oct; 29(10):802-816. PubMed ID: 37591764
[TBL] [Abstract][Full Text] [Related]
8. Early white matter pathology in the fornix of the limbic system in Huntington disease.
Gabery S; Kwa JE; Cheong RY; Baldo B; Ferrari Bardile C; Tan B; McLean C; Georgiou-Karistianis N; Poudel GR; Halliday G; Pouladi MA; Petersén Å
Acta Neuropathol; 2021 Nov; 142(5):791-806. PubMed ID: 34448021
[TBL] [Abstract][Full Text] [Related]
9. Reprint of: Manipulation of microbiota reveals altered callosal myelination and white matter plasticity in a model of Huntington disease.
Radulescu CI; Garcia-Miralles M; Sidik H; Bardile CF; Yusof NABM; Lee HU; Ho EXP; Chu CW; Layton E; Low D; De Sessions PF; Pettersson S; Ginhoux F; Pouladi MA
Neurobiol Dis; 2020 Feb; 135():104744. PubMed ID: 31931139
[TBL] [Abstract][Full Text] [Related]
10. Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease.
Teo RT; Hong X; Yu-Taeger L; Huang Y; Tan LJ; Xie Y; To XV; Guo L; Rajendran R; Novati A; Calaminus C; Riess O; Hayden MR; Nguyen HP; Chuang KH; Pouladi MA
Hum Mol Genet; 2016 Jul; 25(13):2621-2632. PubMed ID: 27126634
[TBL] [Abstract][Full Text] [Related]
11. Early whole-body mutant huntingtin lowering averts changes in proteins and lipids important for synapse function and white matter maintenance in the LacQ140 mouse model.
Shing K; Sapp E; Boudi A; Liu S; Seeley C; Marchionini D; DiFiglia M; Kegel-Gleason KB
Neurobiol Dis; 2023 Oct; 187():106313. PubMed ID: 37777020
[TBL] [Abstract][Full Text] [Related]
12. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.
Mehler MF; Petronglo JR; Arteaga-Bracho EE; Gulinello ME; Winchester ML; Pichamoorthy N; Young SK; DeJesus CD; Ishtiaq H; Gokhan S; Molero AE
J Neurosci; 2019 Mar; 39(10):1892-1909. PubMed ID: 30626701
[TBL] [Abstract][Full Text] [Related]
13. Insights into White Matter Defect in Huntington's Disease.
Sun Y; Tong H; Yang T; Liu L; Li XJ; Li S
Cells; 2022 Oct; 11(21):. PubMed ID: 36359783
[TBL] [Abstract][Full Text] [Related]
14. Mutant huntingtin expression in microglia is neither required nor sufficient to cause the Huntington's disease-like phenotype in BACHD mice.
Petkau TL; Hill A; Connolly C; Lu G; Wagner P; Kosior N; Blanco J; Leavitt BR
Hum Mol Genet; 2019 May; 28(10):1661-1670. PubMed ID: 30624705
[TBL] [Abstract][Full Text] [Related]
15. HIPK3 modulates autophagy and HTT protein levels in neuronal and mouse models of Huntington disease.
Fu Y; Sun X; Lu B
Autophagy; 2018; 14(1):169-170. PubMed ID: 29130397
[TBL] [Abstract][Full Text] [Related]
16. Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model.
Wood TE; Barry J; Yang Z; Cepeda C; Levine MS; Gray M
Hum Mol Genet; 2019 Feb; 28(3):487-500. PubMed ID: 30312396
[TBL] [Abstract][Full Text] [Related]
17. Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
Kratter IH; Zahed H; Lau A; Tsvetkov AS; Daub AC; Weiberth KF; Gu X; Saudou F; Humbert S; Yang XW; Osmand A; Steffan JS; Masliah E; Finkbeiner S
J Clin Invest; 2016 Sep; 126(9):3585-97. PubMed ID: 27525439
[TBL] [Abstract][Full Text] [Related]
18. Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease.
Caron NS; Southwell AL; Brouwers CC; Cengio LD; Xie Y; Black HF; Anderson LM; Ko S; Zhu X; van Deventer SJ; Evers MM; Konstantinova P; Hayden MR
Nucleic Acids Res; 2020 Jan; 48(1):36-54. PubMed ID: 31745548
[TBL] [Abstract][Full Text] [Related]
19. Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific.
Jansen AH; van Hal M; Op den Kelder IC; Meier RT; de Ruiter AA; Schut MH; Smith DL; Grit C; Brouwer N; Kamphuis W; Boddeke HW; den Dunnen WF; van Roon WM; Bates GP; Hol EM; Reits EA
Glia; 2017 Jan; 65(1):50-61. PubMed ID: 27615381
[TBL] [Abstract][Full Text] [Related]
20. Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes.
Hong Y; Zhao T; Li XJ; Li S
J Neurosci; 2017 Sep; 37(39):9550-9563. PubMed ID: 28893927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
